Welcome to LookChem.com Sign In|Join Free
  • or
BENZO[D]OXAZOL-2-YL-N-METHYLMETHANAMINE, also known as MEOP or 2-Methylbenzoxazole-6-carboxamidine, is a chemical compound belonging to the benzoxazole derivatives class. It serves as a crucial building block in pharmaceutical research and development for the synthesis of various pharmaceutical compounds and drug candidates. MEOP's chemical structure and properties make it a valuable intermediate in organic synthesis and medicinal chemistry, with potential applications in the treatment of medical conditions such as cancer and neurological disorders.

136727-12-3

Post Buying Request

136727-12-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

136727-12-3 Usage

Uses

Used in Pharmaceutical Research and Development:
BENZO[D]OXAZOL-2-YL-N-METHYLMETHANAMINE is used as a building block for the synthesis of various pharmaceutical compounds and drug candidates. Its unique chemical structure and properties make it a valuable intermediate in the development of new medications.
Used in Cancer Treatment:
In the field of oncology, BENZO[D]OXAZOL-2-YL-N-METHYLMETHANAMINE is used as a potential therapeutic agent for the treatment of various types of cancer. Its specific mechanism of action and interaction with biological targets are under investigation to determine its efficacy and safety in cancer treatment.
Used in Neurological Disorders Treatment:
BENZO[D]OXAZOL-2-YL-N-METHYLMETHANAMINE is also being studied for its potential applications in the treatment of neurological disorders. Its chemical properties may offer new avenues for the development of medications targeting neurological conditions, providing hope for improved treatment options.
Used in Organic Synthesis:
In the field of organic synthesis, BENZO[D]OXAZOL-2-YL-N-METHYLMETHANAMINE is used as a versatile intermediate for the creation of complex organic molecules. Its reactivity and structural features make it a valuable component in the synthesis of a wide range of organic compounds.
Used in Medicinal Chemistry:
BENZO[D]OXAZOL-2-YL-N-METHYLMETHANAMINE plays a significant role in medicinal chemistry, where it is utilized for the design and synthesis of novel drug candidates. Its unique properties allow researchers to explore its potential in addressing various therapeutic areas, contributing to the advancement of drug discovery and development.

Check Digit Verification of cas no

The CAS Registry Mumber 136727-12-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,6,7,2 and 7 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 136727-12:
(8*1)+(7*3)+(6*6)+(5*7)+(4*2)+(3*7)+(2*1)+(1*2)=133
133 % 10 = 3
So 136727-12-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H10N2O/c1-10-6-9-11-7-4-2-3-5-8(7)12-9/h2-5,10H,6H2,1H3

136727-12-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(1,3-benzoxazol-2-yl)-N-methylmethanamine

1.2 Other means of identification

Product number -
Other names 2-Benzoxazolemethanamine,N-methyl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:136727-12-3 SDS

136727-12-3Downstream Products

136727-12-3Relevant academic research and scientific papers

Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity

-

, (2008/06/13)

Vitronectin receptor antagonists having the formula: STR1 which are useful for the treatment of inflammation, cancer and cardiovascular disorders, such as atherosclerosis and restenosis, and diseases wherein bone resorption is a factor, such as osteoporsis.

N-quinolinyl alkyl-substituted 1-aryloxy-2-propanolamine and propylamine derivatives possessing class III antiarrhythmic activity

-

, (2008/06/13)

This invention relates to N-heteroalkyl-substituted 1-aryloxy-2-propanolamine and propylamine derivatives possessing anti-arrhythmic activity, to pharmaceutical compositions and to methods for production thereof.

Substituted benzimidazole derivatives possessing Class III antiarrhythmic activity

-

, (2008/06/13)

This invention relates to N-heteroalkyl-substituted 1-aryloxy-2-propanolamine and proplyamine derivatives possessing anti-arrhythmic activity, to pharmaceutical compositions and to method for production thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 136727-12-3